Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
The USA-India Chamber of Commerce mission is to provide a pro-active & professional platform for high ranking policy makers, senior business executives, academicians, and investors in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy.
US-India BioPharma & Healthcare Summit
Marriott Cambridge, Massachusetts, USA
June 27, 2014

Master of Ceremonies: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
Welcome Address: Karun Rishi, President, USA-India Chamber of Commerce
Address by: Professor K. VijayRaghavan, Secretary, Department of Biotechnology, Ministry of Science & Technology, Government of India
Address by: Dr. Robert Langer, David H. Koch Institute Professor, MIT

Panel Discussion: Biologics and Biosimilars- How will the future landscape shape out and what are the key challenges to overcome?

Panelists: John Cox, Executive Vice President- Pharma Operations, Biogen Idec; Dr. Richard Gregory, Head of R&D, Sanofi-Genzyme R&D Center; Dr. Mark Schenerman, Vice President- Analytical Biotechnology & Strategy, MedImmune; Rick Srigley, President & CEO, Aragen Bioscience; K.V. Subramaniam, President & CEO, Reliance Life Sciences

Moderator: Thomas Saylor, Chief Executive Officer, Arecor Limited

Panel Discussion:  Industry-Academia Partnerships- Is there a recipe for successful partnerships?

Panelists: Dr. Karen Antman, Dean and Provost, Boston University School of Medicine ; Dr. Sumantra Chattarji, NCBS, Director- Center for Brain Development & Repair, India; Dr. Laurie Glimcher, Dean, Weill Cornell Medical College; Dr. Michael Rosenblatt, Executive Vice President & Chief Medical Officer, Merck & Co.; Dr. Lansing Taylor, Director, University of Pittsburgh Drug Discovery Institute

Moderator: Dr. William Chin, Executive Vice President- Scientific and Regulatory Affairs, PhRMA

Panel Discussion: Reimagining India- Unlocking the potential of Asia’s next superpower

Panelists: Dr. Yasheng Huang, Associate Dean and Professor, Sloan School of Management- MIT; Ambassador Dnyaneshwar Mulay, Consul General of India, New York; Prof. K. VijayRaghavan, Secretary, Department of Biotechnology, Govt. of India; Dr. Srinath Reddy, President, Public Health Foundation of India

Moderator: Adil Zainulbhai, Director Emeritus - India Office, McKinsey & Company

Panel Discussion: Drug Discovery and Collaborative Research- How can emerging markets play a greater role in BioPharma innovation?

Panelists: Dr. Subir Basak, President- Global Drug Discovery Services, Jubilant Life Sciences; Dr. Bahija Jallal, Executive Vice President, MedImmune; Manni Kantipudi, Chief Executive Officer, GVK Biosciences; Dr. Andrew Plump, Deputy President of Global R&D, Sanofi; Dr. Tsutomu Une, Corporate Advisor, Daiichi Sankyo Co., Ltd.

Moderator: Dr. Martin Mackay, Executive Vice President and Global Head of R&D, Alexion Pharmaceuticals

Panel Discussion: Cardiovascular and Metabolic Diseases- Science and research trends- Lessening the disease burden through BioPharma innovation

Panelists: Dr. Caroline Apovian, Professor of Medicine, Section of Endocrinology, Boston University Medical Center; Dr. Daniel Bloomfield, Vice President Clinical Research and  Cardiovascular Therapeutic Area Head, Merck Research Labs; John Brooks, President & CEO, Joslin Diabetes Center; Dr. Philip Larsen, Global Head of Diabetes R&D, Sanofi; Dr. Ming Wang, Vice President and Disease Area Leader of Diabetes, Janssen Pharmaceuticals
Moderator: Sri Mosur, President, Stabilis and Founder, Tanroe

Release of Position Paper by Advisory Board members
Presentation of USA-India Chamber of Commerce commissioned Position Paper by Dr. Ajay Dhankhar, Director and Dr. Jeffrey Smith, Partner - McKinsey & Company

Cocktails and Networking Reception

 

 

 
Delhi Strategy Session
The Oberoi, New Delhi
February 6th, 2014

We regret over 90 senior colleagues could not be accommodated in this meeting due to the nature and format of this Strategy Session. Detailed report with recommendations has been sent to the participants, members and key policy makers.

Co-Chairs:
Prof. K. VijayRaghavan, Secretary, Department of Biotechnology
Dr. Tsutomu Une, Member of the Board, Daiichi Sankyo
Dr. Naresh Trehan, Chairman, Medanta- The Medicity
Dr. G.N. Singh, Drug Controller General of India
Dr. Willard Dere, Senior Vice President & Global CMO, Amgen
D.S. Brar, Chairman, GVK Biosciences
Prof. N.K. Ganguly, former Director General, Indian Council for Medical Research
K.V. Subramaniam, Chief Executive Officer, Reliance Life Sciences
Dr. Narinder Mehra, Dean for Research, All India Institute of Medical Sciences
Dr. Ajay Dhankhar, Director, McKinsey & Company
Karun Rishi, President, USA-India Chamber of Commerce

Delhi Strategy Session reflected on the action agenda emerging from the global summit held in June 2013 in Boston, explored the implications for the decision makers in India and discussed ideas for the June 27, 2014 Boston Summit. McKinsey & Company facilitated the session. We will take the lead to develop deeper perspectives on these issues through detailed stakeholder discussions, interviews and analyses for discussion at the Boston summit in June 2014.

Discussions were held on:

  1. R&D challenges and models: Clinical trials; public-private partnerships
  2. Regulatory environment to spur innovation: How can India play a more leading role?
  3. Biologics & Biosimilars: Can Indian talent and extensive unmet patient needs be used to help drive further growth and development?
  4. Diabetes and Cardiovascular disease: What are disease specific implications on the above topics?

 

 
US-India BioPharma & Healthcare Summit 2013
Marriott Cambridge, Massachusetts, USA
June 21, 2013

Master of Ceremonies - Dr. Martin Mackay, Exe. Vice President and Global Head of R&D, Alexion Pharmaceuticals
Welcome Address: Karun Rishi, President, USA-India Chamber of Commerce
Address by: Dr. Elias Zerhouni, President- Global Research & Development, Sanofi
Address by: Ravinder Jain, IAS, Additional Secretary, Ministry of Health, Govt. of India

Panel Discussion: Oncology: Science and Research Trends – High potential but high cost – Can emerging markets help drive affordable innovation at scale?

Panelists: Dr. Ramesh Deka, Director, All India Institute of Medical Sciences; Dr. Willard Dere, Senior Vice President & International Chief Medical Officer, Amgen; Dr. Ansbert Gadicke, Managing Partner, MPM Capital; Dr. Richard Gaynor, Vice President- Oncology Development, Eli Lilly and Company; Dr. Rakesh Jain, E.L. Steele Laboratory of Tumor Biology, MGH Cancer Center
Moderator: Dr. Raju Kucherlapati, Paul C. Cabot Professor, Dept. of Genetics, Harvard Medical School

Panel Discussion:  Infectious Diseases: Science and Research trends– Can global partnerships address a potentially significant public health challenge?

Panelists: Dr. Jeffrey Chodakewitz, SVP & Franchise Head - Infectious Diseases, Merck & Co.; Dr. Brian Dannemann, Senior Director, J&J Pharmaceutical R&D; Dr. Lynn Marks, SVP- Projects, Clinical Platforms & Sciences, GlaxoSmithKline; Dr. Mark Namchuk, Senior Vice President- Research, Vertex Pharmaceuticals; Dr. G.N. Singh, Drug Controller General of India, Central Drug Control Organization
Moderator: Dr. Manos Perros, Head of Infection iMed & Site Head, Boston R&D, AstraZeneca

Panel Discussion: Industry-Academic Partnerships/Translational Research: Is there a recipe for successful partnerships?

Panelists: Dr. Karen Antman, Dean and Provost, Boston University School of Medicine; Dr. Sanjeevi Carani, Associate Professor, Karolinska Institutet; Dr. JC Gutiérrez-Ramos, Group Senior Vice President, Biotherapeutics R&D, Pfizer; Dr. Ashok Kumar, Vice Chancellor, AKS University; Dr. Sridaran Natesan, Vice President, External Innovation (R&D), Sanofi
Moderator: Dr. William Chin, Executive Dean for Research, Harvard Medical School

Panel Discussion: Funding innovation – Building collaborative platforms and supportive policies to foster innovation

Panelists: Shambhu Kallolikar, IAS, Joint Secretary, Department of Pharmaceuticals, Govt. of India; Peter Michelsen, Managing Director, Goldman Sachs; Dr. Helmut Schühsler, Managing Partner, TVM Capital; Dr. G.N. Singh, Drug Controller General of India, Central Drug Control Organization; K.V. Subramaniam, President & CEO, Reliance Life Sciences
Moderator: Navjot Singh, Director, McKinsey and CompanyPanel Discussion: Drug discovery and Collaborative Research- Are existing R&D models doing enough to address the global productivity challenge?

Panelists: Dr. Subir Basak, President- Global Drug Discovery Services, Jubilant Life Sciences; Dr. Martin Fitchet, Chief Operating Officer, Janssen Research & Development; Dr. Bahija Jallal, Executive Vice President, MedImmune; Dr. Peter Mueller, Exe. Vice President - Global R&D & CSO, Vertex Pharmaceuticals; Dr. Maya Said, Vice President Strategy, Ext. Innovation & Science Policy (R&D), Sanofi
Moderator: Dr. Martin Mackay, Exe. Vice President and Global Head of R&D, Alexion Pharmaceuticals

Strategy Sessions Co-Chairs
Industry Academic Research Partnerships
Dr. Barbara Bierer, Senior Vice President- Research, Brigham and Women’s Hospital
Dr. Sridaran Natesan, Vice President, External Innovation (R&D), Sanofi
Dr. José-Carlos Gutiérrez-Ramos, Senior Vice President, Head of BioTherapeutics R&D, Pfizer

External R&D Strategies
Dr. Subir Basak, President- Drug Discovery Services, Jubilant Life Sciences
Dr. RuiPing Dong, Senior Vice President, Head of Emerging Markets R&D, Merck & Co.
Dr. Jeffrey S. Nye, Vice President, Neuroscience Innovation and Scientific Partnership Strategy
Janssen Research and Development, Johnson and Johnson Innovation

Release of Position Paper by Advisory Board members
Presentation of USA-India Chamber of Commerce commissioned Position Paper by Dr. Ajay Dhankhar, Director and Vikas Bhadoria, Principal - McKinsey & Company

Cocktails and Networking Reception

 

 
Delhi Strategy Session
The Leela Palace, New Delhi
February 1st, 2013

We regret over 100 senior colleagues could not be accommodated in this meeting due to the nature and format of this Strategy Session. Detailed report with recommendations has been sent to the participants, members and key policy makers.


Co-Chairs:
Dr. T. Ramasami, Secretary, Department of Science & Technology
Dr. M.K. Bhan, Former Secretary, Department of Biotechnology
Tsutomu Une, PhD, Member of the Board, Daiichi Sankyo
Richard Mills, JD, Executive Dean, Harvard Medical School
Dr. Naresh Trehan, Chairman, Medanta- The Medicity
Dr. Jagdish Prasad, Director General Health Services, Ministry of Health & Family Welfare
Edward Trimble, MD, MPH Director Global Health, National Cancer Institute
Prof. N.K. Ganguly, Chairman, JIPMER
Sridaran Natesan, PhD, Vice President- External Innovation (R&D), Sanofi US
Rashmi H. Barbhaiya, PhD, Chief Executive Officer, Advinus Therapeutics
Ajay Dhankhar, PhD, Director, McKinsey & Company
Karun  Rishi, President, USA-India Chamber of Commerce

Delhi Strategy Session reflected on the action agenda emerging from the global summit held in May  2012 in Boston, explored the implications for the decision makers in India and discussed ideas for the June 21, 2013 Boston Summit. McKinsey & Company facilitated the session. We will take the lead to develop deeper perspectives on these issues through detailed stakeholder discussions, interviews and analyses for discussion at the Boston summit in June.

Discussion were held on Key Enablers:
A.        Industry Academic Partnerships
B.        Talent and Capability Building
C.        External Research Strategies
D.        Building A Regulatory Environment to Foster Innovation
 

 
US India BioPharma & Healthcare Summit 2012
Hyatt Cambridge, Massachusetts, USA
May 11, 2012
Master of Ceremonies: Dr. William Chin, Executive Dean for Research, Harvard Medical School
Welcome Address: Karun Rishi, President, USA-India Chamber of Commerce
Address By: Dr. Elias Zerhouni, President- Global Research & Development, Sanofi

Strategy Sessions Co-Chairs
Noble Laureate Dr. Phillip Sharp, Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Dr. Sridaran Natesan, Vice President, External Innovation (R&D), Sanofi
Dr. Sanjeev Sinha, Professor- Department of Medicine, All India Institute of Medical Sciences
Dr. RuiPing Dong, Senior Vice President, Head of Emerging Markets R&D, Merck & Co.
Dr. Sandeep Gupta, Sr. Vice President- Early Discovery, Endo Pharmaceuticals
Dr. Rick Connell, VP- External Research Solutions, Pfizer
Sri Mosur, CEO, Global Drug Discovery & Development, Jubilant Life Sciences

Panel Discussion: Industry-Academia Partnerships- Can they drive the next wave of innovation?

Panelists: Dr. Karen Antman, Dean and Provost, Boston University School of Medicine; Dr. Barbara Bierer, Senior Vice President Research, Brigham and Women's Hospital; Dr. Balakrish Nair, Executive Director, Translational Health Science Technology Institute; Dr. Sridaran Natesan, Vice President, External Innovation (R&D), Sanofi; Dr. Phillip Sharp, Institute Professor, Koch Institute for Integrative Cancer Research
Moderator: Dr. William Chin, Executive Dean for Research, Harvard Medical School.

Panel Discussion: Clinical Research- A practical roadmap to achieve more from India

Panelists: Dr. Savita Dhillon, Medical Director, Medanta Duke Research Institute; Dr. Nirmal K. Ganguly, Chairman JIPMER & former Director General ICMR; Dr. Roger Glass, Director, Fogarty International Center, National Institutes of Health; Dr. John Orloff, Senior Vice President, Global Development & CMO, Novartis; Dr. John Sundy, Director- Duke Global Proof of Concept Research Network
Moderator: Dr. Kimberly Wagner, Senior Partner & Managing Director, The Boston Consulting Group

Panel Discussion: Drug R&D and Collaborations- Leveraging India to enhance productivity

Panelists: Dr. Ivan Gergel, Executive Vice President R&D, Endo Pharmaceuticals; Dr. John Leonard, Senior Vice President- Pharmaceuticals R&D, Abbott; Sri Mosur, CEO, Global Drug Discovery & Development, Jubilant Life Sciences; Dr. Rajiv I. Modi, Managing Director, Cadila Pharmaceuticals; Dr. Raja Sekhar Vundru, IAS,  Joint Secretary, Department of Pharmaceuticals, Govt. of India
Moderator: Dr. Maya Said, Vice President Strategy, External Innovation & Science Policy (R&D), Sanofi

Panel Discussion: Funding innovation and investment opportunities in Emerging Markets
Panelists: Dr. RuiPing Dong, Senior Vice President, Head of Emerging Markets R&D, Merck & Co; Dr. Robert King, Senior Partner, Global Healthcare Group, Goldman Sachs; Utkarsh Palnitkar, Executive Director, Centrum Capital Limited; K.V. Subramaniam, President & CEO, Reliance Life Sciences; Dr. Renu Swarup, Managing Director, Biotechnology Industry Research Assistance Council, Government of India
Moderator: Bart Janssens, Partner & Managing Director, The Boston Consulting Group

Panel Discussion: Oncology- Science and Research Trends

Panelists: Dr. Nirmal K. Ganguly, Chairman JIPMER & former Director General ICMR; Dr. Rakesh Jain, E.L. Steele Laboratory of Tumor Biology,  MGH Cancer Center; Dr. Amba Nandakumar, Deputy Director General and  Officer-in-Charge,
National Cancer Registry Programme- Indian Council for Medical Research; Dr. Elad Sharon, Senior Investigator, Investigational Drug Branch, National Cancer Institute; Dr. Chris Takimoto, Vice President, Translational Medicine Early Development, J&J
Moderator: Dr. Raju Kucherlapati, Paul C. Cabot Professor, Department of Genetics, Harvard Medical School

Presentation of USA-India Chamber of Commerce commissioned Position Paper by Bart Janssens, Partner and Rahul Guha, Principal- The Boston Consulting Group

Cocktails and Networking Reception
 

 
   
Post Summit Strategy Session
The Oberoi, New Delhi
November 11th, 2011
 

Co-Chairs:

  • Dr. MK Bhan, Secretary to the Government of India, Department of Biotechnology
  • Dr. Nirmal K. Ganguly, Chairman JIPMER, past Director General- ICMR
  • Dr. T. Ramasami, Secretary to the Government of India, Department of Science & Technology
  • Dr. V.G. Somani, Drug Controller General of India
  • Dr. Sandeep Gupta, Senior Vice President, Endo Pharmaceuticals
  • Sri Mosur, CEO, GDD&D, Jubilant Life Sciences
  • Dr. Sridaran Natesan, Vice President- External Innovation (R&D), Sanofi
  • Karun Rishi, President, USA-India Chamber of Commerce
  • DS Brar, Chairman, GVK Biosciences
  • KV Subramaniam, CEO, Reliance Life Sciences
Program Summary:
Action agenda emerging from USAICís annual global summit
Explore the implications for decision makers in India
Discuss the agenda for the 2012 summit
 
 
US India BioPharma & Healthcare Summit 2011
 Hyatt Regency, Cambridge    
575 Memorial Drive, Cambridge, MA 02139, USA
Thursday, June 23, 2011      
 
Program Summary

Summit Emcee - Dr. Bill Chin, Executive Dean for Research, Harvard Medical School

Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce

Panel Discussion: Drug Discovery and Collaborative Research: Increasing the odds of success

Panelists:
Dr. Martin Fitchet, Chief Operating Officer, Johnson & Johnson Pharma R&D; Dr. Ivan Gergel, Executive Vice President R&D, Endo Pharmaceuticals; Dr. John Leonard, Senior Vice President- Pharmaceuticals R&D, Abbott; Sri Mosur, CEO, Global Drug Discovery & Development, Jubilant Life Sciences; Dr. Peter Mueller, Executive Vice President- Global R&D, Vertex Pharmaceuticals

Moderator: Dr. Bill Chin, Executive Dean for Research, Harvard Medical School

Panel Discussion: "Show me the Money": Funding innovation, investment opportunities and cross border M&A trends in the BioPharma & Healthcare

Panelists:
Hari Bhartia, Co-Chairman & Managing Director, Jubilant Life Sciences; Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital; Robert King, Senior Partner, Global Healthcare Group, Goldman Sachs; Joel Marcus, Chairman & CEO, Alexandria Real Estate Equities; K.V. Subramaniam, President & CEO, Reliance Life Sciences

Moderator: Jeff Elton, Founder & CEO, KEW Group

Panel Discussion: Industry-Academia Partnerships: Can they be the engine of a new wave of innovation?

Panelists:
Dr. Harris Berman, Dean ad interim, Tufts University School of Medicine; Dr. M.K. Bhan, Secretary, Department of Biotechnology, Govt. of India; Dr. Vijay Chandru, Chairman & CEO, Strand Life Sciences; Julius Knowles, Head, Platforms, Strategic Alliances, NIBR (Novartis); Dr. Lansing Taylor, Director, Drug Discovery Institute, University of Pittsburg

Moderator: Dr. Barry Bloom, Distinguished Service Professor, Harvard School of Public Health

Panel Discussion: Diabetes - Science, Research trends and Market Opportunities

Panelists:
Dr. Martin Fitchet, Chief Operating Officer, Johnson & Johnson Pharma R&D; Dr. William Mezzanotte, Vice President- Global Products Leadership, AstraZeneca; Dr. Steven Shoelson, Professor of Medicine, Joslin/Harvard Medical School; Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon; Dr. Suri Venkatachalam, Founder & CEO, Connexios Life Sciences

Moderator: Dr. Paul Strumph, Vice President-Therapeutic Strategy Lead, Quintiles

Panel Discussion: Moving the needle on Drug Development, Clinical Research & other Healthcare opportunities

Panelists:


Dr. Nora Dyer, Head of Search & Evaluation, Novartis Pharmaceuticals; Dr. Nirmal Ganguly, Chairman JIPMER, & ex-Director General ICMR; Krishna Kanumuri, Chief Executive Officer, Sai Advantium; Sanjay Mittal, Director- Research & Clinical Cardiology, Medanta -The Medicity; Debasish Roychowdhury, Head of Global Oncology, Sanofi

Moderator: Dr. Gunther Winkler, Senior Vice President, Biogen Idec

Presentation of USA-India Chamber of Commerce commissioned annual Position Paper by Bart Janssens, Partner, The Boston Consulting Group

Strategy Sessions Co-Chairs
Richard D. Connell, PhD, Vice President and Head of Asia Research, Pfizer
Sandeep Gupta, PhD, Senior Vice President of Drug Discovery & Early Development, Endo Pharmaceuticals
Sri Mosur, President & CEO, Global Drug Discovery & Development, Jubilant Life Sciences
Isaac T. Kohlberg, Senior Associate Provost & Chief Technology Development Officer, Harvard
Sridaran Natesan, PhD, Scientific Site Head - R&D & Head External Innovation & Partnering- NE, Sanofi

Cocktails and Networking Reception


 
   
US India BioPharma & Healthcare Summit 2010
 Hyatt Regency, Cambridge    
575 Memorial Drive, Cambridge, MA 02139, USA
Thursday, May 6, 2010      
 
 
Co-Chair
Dr. Martin Mackay, President Global R&D Pfizer
Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
Mervyn Turner, Chief Strategy Officer, Merck & Company
Dr. Naresh Trehan, Chairman MediCity


Program Summary         Click here to view summit pictures

Master of Ceremonies - Dr. Martin Mackay, President Global R&D Pfizer

Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce

Panel Discussion: Industry-Academia Partnerships
Panelists
: Dr. Allen M Spiegel, Dean, Albert Einstein College of Medicine, Yeshiva University; Balu Balasubramanian, PhD, Managing Director, BMS-Biocon R&D Center; Dr. David Golan, Dean of Graduate Education, Harvard Medical School; Dr. Nirmal Ganguly, Chairman JIPMER, Ex-Director General ICMR; Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon

Moderator: Dr. Barry R. Bloom Distinguished Service Professor, Harvard School of Public Health

Panel Discussion - Funding innovation, investment opportunities and cross border M&A trends in US-India BioPharma & Healthcare Panelists: Joel Marcus, Chariman and CEO, Alexandria; K.V. Subramaniam, President & CEO, Reliance Life Sciences; Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital; Utkarsh Palnitkar, Executive Director, Centrum Capital Limited; Brian Atwood, Founding Partner, Versant Ventures
Moderator: Jeff Elton, Founder & CEO, KEW Group

Presentation by: Dr. Marc Cluzel, Executive Vice President & Global Head of R&D, Sanofi aventis - From Preferred Partner to Preferred Network

Presentation by: Dr. Mervyn Turner, Chief Strategy Officer & Senior Vice President Emerging Markets R&D, Merck & Co. - How can India foster innovation in Health Care?

Panel Discussion: Collaborative Research and Drug Discovery
Panelists
: Dr. David Lacey, Senior Vice President- Research, Amgen; Dr. Peter Mueller, Executive Vice President, Global R&D & CSO, Vertex Pharmaceuticals; Sri Mosur, Chief Executive Officer, Jubilant Biosys; Dr. Paul Stoffels, Global Head- R&D Pharma, Johnson & Johnson; Davinder Brar, Chairman, GVK Biosciences
Moderator: Dr. Martin Mackay, President PharmaTherapeutics R&D, Pfizer

Presentation by: Dr. Rod MacKenzie, Senior Vice President & Head of Worldwide Research, PharmaTherapeutics, Pfizer - Pfizer in India

Panel Discussion: Drug Development, Clinical Research & Healthcare opportunities
Panelists
: Dr. Michael Rosenblatt, Executive Vice President & Chief Medical Officer, Merck & Co.; Dr. Sanjay Mittal, Director-Clinical Cardiology & Research, Medanta, The Medicity; Dr. Nirmal Ganguly, Chairman JIPMER, Ex-Director General ICMR; Dr. Paul Stoffels, Global Head- R&D Pharma, Johnson & Johnson; Dr. Robert Taber Vice Chancellor- Corporate & Venture Devp, Duke University Medical
Moderator: Alka Goel, Associate Principal, McKinsey & Company

Presentation of USA India Chamber of Commerce commissioned McKinsey & Company Position Paper.
Ajay Dhankar and Vikas Bhadoria

Closing Remarks - Dr. Gunther Winkler, Sr. Vice President, Biogen Idec 

Cocktails and Networking Reception


 
Pharmaceuticals & Healthcare Brainstorming Session
with a group of 30 Lok Sabha and Rajya Sabha Members of Parliament, India, Constitution Club, New Delhi
December 4, 2009

Chaired by Honorable Srikant Jena, Minister of State for Chemicals & Fertilizers
Opening Remarks- Karun Rishi, President, USA-India Chamber of Commerce
Moderated by- Prof. Barry Bloom, Past Dean, Harvard School of Public Health

 



 
 

 
India Pharma Summit

November 30, 2009
Grand Hyatt, Mumbai, India
Organized by Department of Pharmaceuticals
Government of India

Click here for program details
 

 
2009-10 Meetings & Roundtables by USA-India Chamber of Commerce  
  1. Honorable Kamal Nath, Minister of Commerce and Industry
  2. Honorable Ashwani Kumar, Minister of State, Ministry of Commerce & Industry
  3. Gopal Pillai, Secretary, Department of Commerce, Ministry of Commerce & Industry
  4. Ajay Shankar, Secretary, Department of Industry, Ministry of Commerce & Industry
  5. Dr, Ajay Dua, Advisor, Department of Industry, Ministry of Commerce & Industry
  6. R. Gopalan, Additional Secretary; Jayant Dasgupta, Joint Secretary; PK Dash, Joint Secretary; Rajeev Kher, Joint Secretary; Amarendra Khatua, Joint Secretary, Ministry of Commerce & Industry
  7. Honorable Dr. Anbumani Ramadoss, Union Minister of Health & Family Welfare
  8. Naresh Dayal, Secretary, Ministry of Health & Family Welfare
  9. Dr. Surinder Singh, Drug Controller General of India
  10. Director General, Indian Council of Medical Research (ICMR)
  11. Ratan Tata, Chairman, Tata Sons and Co-Chairman of US-India CEO Forum
  12. Honorable Prithviraj Chauhan, Minister of State, Prime MinisterÂ's Office
  13. C.B. Bhave, Chairman, Securities and Exchange Board of India
  14. Shivshankar Menon, Foreign Secretary, Ministry of External Affairs
  15. Honorable. Kapil Sibal, Minister of Science & Technology and Earth Sciences
  16. Dr. M.K. Bhan, Secretary, Department of Biotechnology
  17. N.S. Samant, Joint Secretary, Department of Biotechnology
  18. Ashok Kumar, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Petrochemicals
  19. Satwant Reddy, Advisor; Ministry of Chemicals & Petrochemicals
  20. Gurdyal Singh Sandhu, Joint Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Petrochemicals
  21. Arun Ramanathan , Secretary, Ministry of Finance
  22. Madhusudan Prasad, Joint Secretary; Kumar Sanjay Krishna, Joint Secretary, Ministry of Finance
  23. Honorable Subodh Kant Sahai, Minister of State, Ministry of Food Processing Industries
  24. Under Secretary, US Department of Commerce
  25. Assistant Secretary, US Department of Commerce
  26. Associate Administrator, Small Business Administration
  27. Honorable Montek Singh Ahluwalia, Deputy Chairman, Planning Commission
  28. Minister of Communication & IT
  29. Jainder Singh, Secretary, Department of IT, Ministry of Communications & IT
  30. Siddhartha Behura, Secretary, Department of Telecom, Ministry of Communications & IT
  31. Tejendra Khanna, Lt. Governor Delhi
  32. Chief Minister, Government of Karnataka
  33. Katta Naidu, Minister of IT/BT and Revenue, Government of Karnataka
  34. Secretary- Information Technology, Development Commissioner (Industries), Member Secretary Maharashtra Biotechnology Commission, Government of Maharashtra
  35. Industry, Industry organizations, State and Federal officials in the US
 

 
Business Roundtable and Post Summit follow up with Ashok Kumar
Secretary to the Government of India, Department of Pharmaceuticals

Monday, June 22, 2009
12:00 pm - 2:00 pm
Location: Harvard Faculty Club, Cambridge, MA
 
Opening remarks Prof. Barry R. Bloom, Harvard School of Public Health
Remarks Karun Rishi, President, USA-India Chamber of Commerce

Q&A and Open Discussion

Business Roundtable open to C level and senior executives from Healthcare, Pharma, Biotech, Medical Devices, Investment firms and Academia.
 

 
US India BioPharma & Healthcare Summit 2009
 Hyatt Regency, Cambridge    
575 Memorial Drive, Cambridge, MA 02139, USA
Thursday, May 14, 2009      
 
 
Co-Chair
Dr. Martin Mackay, President Global R&D Pfizer
Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
Dr. Naresh Trehan, Chairman MediCity
Jeff Elton, Life Sciences Investor & Consultant

Opening remarks: Karun Rishi, President-USA-India Chamber of Commerce

Release of USA-India Chamber of Commerce commissioned McKinsey & Company Position Paper by Dr. Martin Mackay, President Global R&D Pfizer.

Panel Discussion: Healthcare, Clinical Research and Industry-Academic Partnerships
Panelists :  Dr. Gerald Keusch, Associate Provost, BU School of Public Health, Dr. David Lacey, Senior Vice President & Head of Research, Amgen, Dr. Michael Rosenlatt, Dean Tufts University School of Medicine, Joe Smith, MD, PhD, Vice President-Emerging Technologies, Johnson & Johnson, Sridhar Mosur, Chief Executive Officer, Jubilant Biosys
Moderator: Dr. William Chin, Vice President - Discovery Research & Clinical Investigation, Eli Lilly & Company

Introduction by Manni Kanti Pudi, President, GVK BioSciences

Keynote Address: Dr. Martin Mackay, President, Pfizer Global Research & Development

Panel Discussion: Funding Innovation, Cross Border Investment and M&A Trends
Panelists:  K.V.Subramaniam, President & CEO, Reliance Life Sciences; Jeff Collins, Executive in Residence, Pappas Ventures; Jeffrey Elton, Life Sciences Investor & Consultant; George Bickerstaff, Managing Director, CRT Investment Banking; Shrikumar Suryanarayan, Director General, ABLE
Moderator: Glen Giovanneti, Global Biotechnology Leader, Ernst & Young

Introduction: Banashri Bose Harrison, Minister (Commerce), Embassy of India

Keynote Address by Nobel Laureate Dr. Sidney Altman

Presentation by Department of Pharmaceuticals, Govt of India. Paresh Johri, Deputy Secretary

Panel Discussion: Drug discovery, Development and Collaborative Research
Panelists
:  Robert Armstrong, PhD, Vice President, Global External R&D, Eli Lilly; Venkat Jasti, Chairman & CEO, Suven Life Sciences; Ismail Kola, PhD, Senior Vice President- Discovery Research & Chief Scientific Officer, Schering-Plough; CSN Murthy, Chief Executive Officer, Aurigene Discovery; Dr. John Thompson, Vice President, Strategic Research Alliances, Vertex

Moderator: Ramesh Srinivasan, Principal, McKinsey and Company

Introduction: Reid Leonard, PhD, Executive Director, External Research & Licensing, Merck & Co.

Presentation of distinguished services award to Dr. Barry R. Bloom

Introduction by Dr. Gerald Keusch, Associate Provost, BU School of Public Health

Award Presentation by Dr. Martin Mackay and Karun Rishi

Address by Dr. Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Department of Immunology and Infectious Diseases, Harvard School of Public Health

Closing Remarks - James Mullen President & CEO, Biogen Idec 

Cocktails and Networking Reception


 
US India BioPharma & Healthcare Summit 2008      

Hyatt Regency, Cambridge    
Friday, June 13, 2008      
 
Master of Ceremonies: Hon. Andrew Maguire, PhD, Executive Director-GAVI

Opening remarks: Karun Rishi, President USA-India Chamber of Commerce

Presentation of USA-India Chamber of Commerce commissioned McKinsey & Company Position Paper

Panel Discussion: Drug Discovery, Collaborative Research and Strategic Alliances

Panelists:
    Dr. William Chin, Vice President - Discovery Research, Eli Lilly
    Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences
    Dr. Peter Mueller, Exe. Vice President & CSO, Vertex Pharmaceuticals
    Barbara Yanni, Chief Licensing Officer, Merck & Co.
    Dr. Rashmi Barbhaiya, Co-Founder and CEO, Advinus Therapeutics
Official Release of Position Paper and Keynote address by Honorable Kapil Sibal, Minister of Science & Technology and Earth Sciences, Government of India
Networking and Tea Break
Panel Discussion: Funding Innovation, Investment Opportunities, Cross Border M&A trends

Panelists:
    Frederick Frank, Vice Chairman & Director, Lehman Brothers
    Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
    Tom Andrews, Senior Vice President, Alexandria Real Estate Equities
    Sri Mosur, President & CEO, Jubilant Biosys Ltd.
    Dr. Jasmin Patel, Managing Director, Fidelity Capital Management (India)
Keynote address by Dr. Surinder Singh, Drug Controller General of India
Introduction: James Mullen, President & CEO, Biogen Idec and past Chairman, Biotechnology Industry Organization (BIO)

Keynote address by Dr. Joshua Boger, President & CEO, Vertex Pharmaceuticals and Chairman, Biotechnology Industry Organization (BIO)

Panel Discussion: Drug Development & Manufacturing, Clinical Research and In/Out Licensing
Panelists:
    Dr. Mark Powell, Sr VP & Worldwide Head-Pharmaceutical Development, Bristol Myers & Squibb
    Gregg Alton, Senior Vice President, Gilead Sciences
    Dr. Gunther Winkler, Sr. Vice President, Biogen Idec
    Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.
    Dr. Dianne Kikta, Vice President Global Clinical, Wyeth
    Dr. Sreeni Devidas, Vice President, GVK BioSciences

Closing Remarks
Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce
Cocktails and Networking Reception

 
US India BioPharma & Healthcare Summit - 2007          

 Monday, May 7              
Hotel Omni Parker House
                 
60 School Street, Boston, MA 02108, USA         
 
2007 Summit Pictures

Welcome address: Karun Rishi, President, USA-India Chamber of Commerce
Opening remarks: James C. Mullen, Chairman Biotechnology Industry Organization (BIO), CEO & President, Biogen Idec

Release of USA-India Chamber of Commerce commissioned Ernst & Young Position Paper on Indian Biotech industry
Panel Discussion: Discovery, Development, IP & Regulatory Issues
Panelists:
   Dr. Alan Smith, Chief Scientific Officer, Genzyme
   Dr. Peter Mueller, Chief Scientific Officer, Vertex Pharmaceuticals
   Dr. Rashmi H.Barbhaiya, CEO and MD, Advinus Therapeutics
   Dr. Sridhar Mosur, Managing Director, Jubilant Chemsys Ltd
   Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.

Moderator:
   David C U'Prichard, PhD,
   Partner, Red Abbey Venture Partners and Care Capital

Keynote Address:
   Dr.M.K.Bhan, Secretary-Govt of India, Dept of Biotechnology
   Introduction to Dr. MK Bhan by Joel Marcus,
   CEO of Alexandria Real Estate Equities

Panel Discussion: Investment Opportunities, Cross Border Investments, M&A Trends in US-India Life Sciences industry

Panelists:
   Dr. Helmut M. Schühsler, Managing Partner, TVM Capital
   Dr. David Gluckman, MD & Head of European Life Sciences, Lazard
   George Bickerstaff, Managing Director, CRT Capital Group
   Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd
   Dr. Stephen Knight, Managing Partner, Fidelity Biosciences

Moderator:
   Utkarsh Palnitkar , Partner-Transaction Advisory Services,
   Industry Leader - Health Sciences, Ernst & Young

Closing remarks: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce

Cocktails & Networking Reception

 
The Deal's BRIC Symposium
April 12, 2007           Agenda & Registration
Location: The Westin New York at Times Square
USA-India Camber of Commerce is the Association Partner of BRIC Symposium. USAIC members save 15% off the The Deal's BRICs Symposium.

M&A and Investment opportunities in key emerging economies continue to thrill and terrify US professionals. In this one-day symposium, an audience of bankers, strategic acquirers, private equity partners and other alternative investment will gather in New York to hear the strategies and perspective of the leading investors and dealmakers who are having significant success currently in Brazil, Russia, India and China (BRIC).
 

 
India Healthcare Luncheon Business Roundtable
India Healthcare Luncheon Business Roundtable with Dr. Anbumani Ramadoss, Honorable Union Minister of Health, Government of India and Prof. N.K. Ganguly, Director General, Indian Council of Medical Research (ICMR).

Opening remarks: Prof. Barry R. Bloom, Dean, Harvard School of Public Health
Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Q&A and open discussion

Date: Friday, March 30, 2007

Location: Harvard Faculty Club, Cambridge, MA
  • Opportunities in the Indian Healthcare industry
  • Opportunities in India for US Healthcare, Biotech, Pharma and Medical Device companies
  • Public-Private partnership in Indian Healthcare
Business Roundtable open to C level and senior executives from Healthcare, Pharma, Biotech, Medical Devices, Investment firms and Academia.

Event is complementary for members.

 
 
   

 
India Business Summit
Special focus on opportunities for US SME companies in India. The two day conference besides several keynotes will have sessions on IT, ITeS, Retail, Real Estate, Food Processing, Auto and Auto Components, Financing, Entrepreneurship, Policy, Market Access, Emerging sectors and Export opportunities.

Senior policy makers and key executives from Walmart, Citigroup, Bank of America, SBA, Coca-Cola, Kelloggs, Tishman Spyer, Parsons, IBM, Hero Group, UPS, Bharti, General Motors, EXIM Bank, and Proctor & Gamble etc will participate in the panel discussions.

Place: Maurya Sheraton Hotel, New Delhi, India

Date: Jan 23-25, 2007
 
   

 
India Healthcare Business Roundtable
Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce

Remarks by Prof K. Srinath Reddy, Professor and Head, Department of Cardiology, All India Institute of Medical Sciences (AIIMS) and President, Public Health Foundation of India

Remarks by Prof. Barry R. Bloom, Dean, Harvard School of Public Health

Q&A and open discussion

Closing Remarks: Stephen Knight, Managing Partner, Fidelity Biosciences

Date: Wednesday, December 6, 2006

Location: Downtown Harvard Club Boston, Massachusetts

The discussion will focus on:
  • Opportunities for US Pharma, Biotech and Medical Device companies
  • Public-Private partnership in healthcare
  • Public Health Foundation of India
  • AIIMS research initiatives in electrophysiology, cardiomyopathies, gene therapy and stem cell therapy
Prof Reddy was recently appointed President of the Public Health Foundation of India. Dr. Reddy Chairs numerous healthcare commissions and committees in India and internationally.

Exciting things are happening in IndiaÂ’s healthcare sector. Industry, Academia, Research institutions and Investors in the US need to take a serious look at India opportunity. This roundtable is only for senior executives.

Event is complementary for members.
 

 
BUSINESS DEVELOPMENT MISSION TO INDIA
November 29 to December 5, 2006
USA-India Chamber of Commerce is pleased to support the Business Development Mission led by Amb. Franklin L. Lavin, Under Secretary for International Trade, U.S. Department of Commerce. This precedent-setting initiative, potentially involving the largest ever overseas delegation of its kind led by a U.S. Government official, will serve as the capstone of a year of successful activities conducted under the auspices of the U.S.-India Commercial Dialogue, honoring the commitment of President Bush and Indian Prime Minister Manmohan Singh to revitalize bilateral trade discussions.

This is a great opportunity to get access to IndiaÂ’s high-level business, industry, and government representatives and opportunities to gain timely insights into the countryÂ’s trade and investment climate.

We strongly recommend and encourage you participate and benefit from this important business mission to India.

For details please visit India Mission
 

 
The New York Society of Security Analysts in association with USA-India Chamber of Commerce presents ‘Investing in Asia’ conference.

Date: Thursday, September 28, 2006

Location: NYSSA, 1177 Avenue of the Americas, 2nd floor
          (between 45th and 46th Streets), New York, NY 10036

          Photo ID required for access to the building.

Credit: PD/CE/CPE = 1

Asia has become a crucial part of the global economy, boasting three of the ten largest economies—China, Japan, and India—and contributing more than 35% of world GDP. Investment has been booming in recent years, with Asia accounting for about 40% of net private capital flows into emerging markets.

The region’s economy is now the fastest growing in the world, and contributes close to 50% of global growth. Aggregate GDP for Asia expanded by a robust 7.4% in 2005. This growth has been supported by a favorable external environment and continuing progress on domestic reform issues. Experts expect China and India to continue to be the fastest-growing countries in the region, with projected 2006 GDPs of 9.5% and 7.3%, respectively.

Where are the next best investment opportunities in Asia? Hear from the senior executives of growing public companies from the region, and learn what leading experts have to say about AsiaÂ’s economic outlook.
 

 
USA-India Chamber of Commerce presents Business Lunch Roundtable with David Bohigian, Assistant Secretary, International Trade Administration, U.S. Department of Commerce.

Program

Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Introduction: Nigel Thompson, Executive Director, Merck
Business Roundtable with David Bohigian, Assistant Secretary, U.S. Department of Commerce
Closing Remarks: Michael Fondo, Director, Fidelity Investments

Date: Tuesday, May 2, 2006.

Location: Fairmont Copley Plaza Hotel, Boston

Assistant Secretary BohigianÂ’s Market Access and Compliance (MAC) division identifies and overcomes trade barriers, resolves trade policy issues, and ensures that our trading partners fully meet their obligations under our trade agreements. MAC ensures access to world markets for American companies.

MAC focuses on issues such as: Intellectual Property and Piracy, Quotas, Standards, Customs, Transparency and Contract Sanctity, National Treatment and Good Governance.

This roundtable is only for senior executives.

Event is complementary for members.
 

 
Annual International Business Forum and Networking Evening

Date: Tuesday, May 2, 2006.
Location: One Financial Center, Boston, MA 02111

The Global Economic Outlook: Implications for International Business in the Year Ahead: Christopher Probyn, Chief International Economist, State Street Corporation

Keynote speaker: David Bohigian, Assistant Secretary, US Department of Commerce
Panel discussion: Assessing & Managing Risk in the Global Marketplace

The business forum will kick off with a Global Economic Outlook seminar, which will include information on global market indicators and implications for international business in the year ahead. The forum will also include a session on Assessing and Managing Risk in the Global Marketplace, featuring panelists who will discuss techniques for assessing and mitigating various risks of doing business internationally: global security; political, economic and credit risk; intellectual property protection and commercial risks; and regulatory compliance.
 

 
Interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India

Date: Tuesday, March 14, 2006
Location: Downtown Boston

USA-India Chamber of Commerce presents an interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India, Washington DC. He is a senior diplomat and a key person responsible for trade and exim policy issues. He is also an expert on WTO issues. This will be the first briefing nationally discussing the trade agreements signed last week during President Bush's India visit.

Agenda:
  • Important trade agreements signed during President Bush's India visit & its impact on US-India trade.
  • Opportunities in India: Best prospect sectors for US companies
  • Indian Budget 2006 highlights- Budget was presented to the Indian parliament on Feb 28.
  • Q & A
This event is complementary for our members.
 

 
USA-India Chamber of Commerce and USIBC present an Executive Luncheon Business Roundtable with Satwant Reddy, Secretary to Government of India, Ministry of Chemicals. She is the top ranking official in the ministry. Her portfolio includes the regulation of all state-owned chemical companies, pharmaceuticals, and petrochemicals. Among other things, she is tasked responsibility for formulating India ’s data exclusivity and pharmaceutical price control policies

Date: January 27, 2006
Location: Downtown Boston

It is a member’s only event for senior executives. This event is complementary for our members.
 

 
Jan 26, 2006

Dinner meeting with Ms. Satwant Reddy, Secretary to Government of India, Ministry of Chemicals & Petrochemicals and Prof. Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School and author of the book: 'Innovation and Its Discontents’: How Our Broken Patent System is Endangering Innovation and Progress. Exclusively for members and sponsors.

This roundtable is only for senior executives.

Event is complementary for members.
 
   
© 2007 - 2014 USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us